Sorry, you need to enable JavaScript to visit this website.

GENOTROPIN (somatropin [rDNA origin] for injection) Overdosage

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Overdosage

For management of a suspected drug overdose, contact your regional Poison Control Centre.

Short-Term

There is little information on acute or chronic overdosage with GENOTROPIN (somatropin for injection). It is known that intravenously administered growth hormone has been shown to result in an acute decrease in plasma glucose and subsequently to hyperglycemia. It is thought that the same effect might occur on rare occasions with high dosages of GENOTROPIN administered subcutaneously or intramuscularly.

Long-Term

Long-term overdosage may result in signs and symptoms of acromegaly consistent with overproduction of human growth hormone.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111